P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,279.85
122.3 (2.37%)
BSENSE

Oct 09

BSE+NSE Vol: 7.68 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 346859,
    "name": "P & G Health Ltd",
    "stock_name": "P & G Health Ltd",
    "full_name": "Procter & Gamble Health Ltd",
    "name_url": "stocks-analysis/p-g-health",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,279.85",
    "chg": 122.3,
    "chgp": "2.37%",
    "dir": 1,
    "prev_price": "5,157.55",
    "mcapval": "8,579.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500126,
    "symbol": "PGHL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE199A01012",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "7.68 k",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mercks New Keytruda Shot Blocked in Europe After Court Loss",
        "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNODdiM1ViSkRGaHpBVnhEd0pmMk5vQkIxR3p5UlZXUEZldkU0ZFVEdGIzMTBPQjRWNWpxbDM0eTV4UFlxVmRrMlF6Q3M3cDBOTlBDVS1KcnAybURINENsLWgxYk5BOExGQmZJYjlTWG9mTkc2YU14akNLQnA5OUhzYzhicDByWHFrUnJnMFNyNGZOT01aMHprdmF2d3E1VVVaSDl2enNrYVBuZjZ5bG45Yg?oc=5",
        "imagepath": "",
        "date": "2026-10-07 19:18:07",
        "description": "Mercks New Keytruda Shot Blocked in Europe After Court Loss  Bloomberg.com..."
      },
      {
        "title": "Halozyme wins court order to block Merck\\'s injected Keytruda in select European markets",
        "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQOENfMU9mT1RqQTl2QlZBUjgzTi1ZTFZWZThEMXk5YTJRMC1jSlA4VGRQX1p0a2tmQ2ppc0M4bURDLUdJTDBkQVNOcGFrYi1rWTU3Wjk1Uk44Y2QyMEx2MmlyS2drLWRQUFRUTW1VNEZteW56VEVWQjBQTFBNQmxWMGk3ZGpGRXlFX3liNjJxd3l1ZUI0OFlFczRpRjRlekU1UUhNSnZhNks0TndBV2lCMnJnd0EyNXRaR2pRWE1lTGhxVjBUMVVMRFB0RFpKUQ?oc=5",
        "imagepath": "",
        "date": "2026-10-07 19:03:34",
        "description": "Halozyme wins court order to block Merck\\'s injected Keytruda in select European markets  Reuters..."
      },
      {
        "title": "Merck\\'s experimental skin disease drug succeeds in mid-stage study",
        "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNX2dneUVmM2V6anN4UXpfRGFJdW1qb3Y4N2d4bXh5SWNDRkRtTWIyZ1FXMjJrbDhJYWgtVXAtWjZ0cjdTUFNqN1RicUhFTXUtN1ZmbnZiNjZqVjJLRkJBTmRqUVVlWTZ2Nk45OFFPV0JFSVEyQVZEc2ctLUFVVDcwZE9QVVRDdTFGYTR3RUFDX2RpQUQ0cmhXakQ4bWQwT2xtZ3VUR0hFVTlaczA0NWFhZk1JYkRiU0xuY1hxZzZSMWZySDBIYU42cTFoV3ZWRWRCS1NjNjRKQVVHaVpITkE?oc=5",
        "imagepath": "",
        "date": "2026-09-30 20:53:26",
        "description": "Merck\\'s experimental skin disease drug succeeds in mid-stage study  Reuters..."
      },
      {
        "title": "Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion",
        "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQNDdBQWp0eXhySGlJdTloSFcwMVk1WmY1NzVlZldsRDZRTjRRdy0zTHVCbXU5QjRlSWdFWmI2OGNXNmN6SHp2dF9oOEItN1E2dl9kSnZjZVYwT096T1V0aUpvT0pzX29aWVhILVBLMDdZMkRQX2VsZHBrRUJuT3phY1MzQ2Rlcy12OEZWTm9XWG12YmZDVkI1cU1ObWtzNzJOcEN1MklZZ2dQWWxMRGJMQThLZFdFZw?oc=5",
        "imagepath": "",
        "date": "2026-09-28 21:44:32",
        "description": "Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion  Reuters..."
      },
      {
        "title": "Moderna-Merck Cancer Vaccine in the Balance",
        "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNUnl1NkR4Tlp0SThfOVEzdUZWODV3MUY2amtzdEtaREIwMTZoYnlQMkIwQTZxb2FnYXowQXZxOUh2bzJIUWNnbGJaQVNmQ2dDOHU4NnBOWXI4WHdyaE40ZUZjaXB1NzNQcWUwRVNMd0ViUXB5cEU3Y0dSdmN2dmNKVW9OSHo3MGx3eVZfZkRqU1dzMmZJMktBYkVyWk9aVmV5bEE?oc=5",
        "imagepath": "",
        "date": "2026-09-21 15:53:13",
        "description": "Moderna-Merck Cancer Vaccine in the Balance  Bloomberg.com..."
      }
    ],
    "total": 5,
    "sid": "346859",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/procter-gamble-health-346859"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Oct-2026",
      "details": "Please find attached signed Certifiacte for confirming compliance under Regulation 74(5) of the SEBI (DP) Regulations for the quarter ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting",
      "datetime": "30-Sep-2026",
      "details": "Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Sep-2026",
      "details": "We would like to inform you that the Trading Window of the Company shall remain closed for the Directors and Designated Employees from October 1 2026 until 48 hours from the publication of the unaudited financial results for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "02 Nov 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Procter & Gamble Health Ltd has declared <strong>450%</strong> dividend, ex-date: 27 Aug 26",
          "dt": "2026-08-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Oct-2026 | Source : BSE

Please find attached signed Certifiacte for confirming compliance under Regulation 74(5) of the SEBI (DP) Regulations for the quarter ended September 30 2026.

Board Meeting Intimation for Intimation Of Board Meeting

30-Sep-2026 | Source : BSE

Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2026.

Closure of Trading Window

25-Sep-2026 | Source : BSE

We would like to inform you that the Trading Window of the Company shall remain closed for the Directors and Designated Employees from October 1 2026 until 48 hours from the publication of the unaudited financial results for the quarter and half year ended September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

02 Nov 2026

stock-summary
DIVIDEND

Procter & Gamble Health Ltd has declared 450% dividend, ex-date: 27 Aug 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available